Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VegInvest is a mission-driven venture capital firm that provides early-stage capital and strategic guidance to companies aiming to replace animal-derived products in the food system and other industries. Founded in 2015 and headquartered in New York, the firm focuses on three core sectors: food technology, biology (including synthetic biology and alternatives to animal testing), and plant-based restaurants. VegInvest's portfolio includes pioneering biotechnology and cellular agriculture companies such as Geltor, Mosa Meat, BlueNalu, and Emulate. The firm is dedicated to building a sustainable, ethical, and reliable food system by supporting innovations that improve the taste, safety, and cost of animal-free products. By leveraging its expertise in biology and food science, VegInvest helps entrepreneurs scale transformative technologies that reduce global reliance on animal exploitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VegInvest.